Deconvoluting hepatic processing of carbon nanotubes
Application of carbon nanotubes as drug delivery carriers is stalled by uncertainties over their distribution and toxicity in vivo. Here, the authors use animal models to show that, while the bulk of nanotubes is renally cleared, a fraction can be eliminated through an alternative hepatobiliary path...
Guardado en:
Autores principales: | Simone Alidori, Robert L. Bowman, Dmitry Yarilin, Yevgeniy Romin, Afsar Barlas, J. Justin Mulvey, Sho Fujisawa, Ke Xu, Alessandro Ruggiero, Vladimir Riabov, Daniel L. J. Thorek, Hans David S. Ulmert, Elliott J. Brea, Katja Behling, Julia Kzhyshkowska, Katia Manova-Todorova, David A. Scheinberg, Michael R. McDevitt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/423150c700094e65a6244050ab69116e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes [Erratum]
por: Mulvey JJ, et al.
Publicado: (2015) -
Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes
por: Mulvey JJ, et al.
Publicado: (2014) -
The effects of amine-modified single-walled carbon nanotubes on the mouse microbiota
por: Mulvey JJ, et al.
Publicado: (2018) -
Benchmarking pipelines for subclonal deconvolution of bulk tumour sequencing data
por: Georgette Tanner, et al.
Publicado: (2021) -
Deconvoluting complex structural histories archived in brittle fault zones
por: G. Viola, et al.
Publicado: (2016)